Detalhe da pesquisa
1.
Regional and bilateral MRI and gene signatures in facioscapulohumeral dystrophy: implications for clinical trial design and mechanisms of disease progression.
Hum Mol Genet
; 33(8): 698-708, 2024 Apr 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38268317
2.
Elevated plasma complement components in facioscapulohumeral dystrophy.
Hum Mol Genet
; 31(11): 1821-1829, 2022 06 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34919696
3.
Longitudinal course of neurofilament light chain levels in amyotrophic lateral sclerosis-insights from a completed randomized controlled trial with rasagiline.
Eur J Neurol
; 31(3): e16154, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37975796
4.
Phase 2 trial in acetylcholine receptor antibody-positive myasthenia gravis of transition from intravenous to subcutaneous immunoglobulin: The MGSCIg study.
Eur J Neurol
; 30(5): 1417-1424, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36779862
5.
Longitudinal measures of RNA expression and disease activity in FSHD muscle biopsies.
Hum Mol Genet
; 29(6): 1030-1043, 2020 04 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32083293
6.
Self-reported reduced sleep quality and excessive daytime sleepiness in facioscapulohumeral muscular dystrophy.
Muscle Nerve
; 66(4): 487-494, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35893768
7.
Non-dystrophic myotonia: 2-year clinical and patient reported outcomes.
Muscle Nerve
; 66(2): 148-158, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35644941
8.
Brief assessment of cognitive function in myotonic dystrophy: Multicenter longitudinal study using computer-assisted evaluation.
Muscle Nerve
; 65(5): 560-567, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35179228
9.
Quantitative muscle analysis in facioscapulohumeral muscular dystrophy using whole-body fat-referenced MRI: Protocol development, multicenter feasibility, and repeatability.
Muscle Nerve
; 66(2): 183-192, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35585766
10.
Randomized phase 2 study of ACE-083, a muscle-promoting agent, in facioscapulohumeral muscular dystrophy.
Muscle Nerve
; 66(1): 50-62, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35428982
11.
Predictors of functional outcomes in patients with facioscapulohumeral muscular dystrophy.
Brain
; 144(11): 3451-3460, 2021 12 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-34542603
12.
Long-term efficacy and safety of dichlorphenamide for treatment of primary periodic paralysis.
Muscle Nerve
; 64(3): 342-346, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34129236
13.
The facioscapulohumeral muscular dystrophy Rasch-built overall disability scale (FSHD-RODS).
Eur J Neurol
; 28(7): 2339-2348, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33838063
14.
Guidelines on clinical presentation and management of nondystrophic myotonias.
Muscle Nerve
; 62(4): 430-444, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32270509
15.
Magnetic resonance imaging correlates with electrical impedance myography in facioscapulohumeral muscular dystrophy.
Muscle Nerve
; 61(5): 644-649, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31884698
16.
A pilot study of the responsiveness of wireless motion analysis in facioscapulohumeral muscular dystrophy.
Muscle Nerve
; 60(5): 590-594, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31443130
17.
Limb-girdle muscular dystrophy: A perspective from adult patients on what matters most.
Muscle Nerve
; 60(4): 419-424, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31298728
18.
Rasagiline for amyotrophic lateral sclerosis: A randomized, controlled trial.
Muscle Nerve
; 59(2): 201-207, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30192007
19.
Clinical trial readiness to solve barriers to drug development in FSHD (ReSolve): protocol of a large, international, multi-center prospective study.
BMC Neurol
; 19(1): 224, 2019 Sep 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31506080
20.
Electrical impedance myography in facioscapulohumeral muscular dystrophy: A 1-year follow-up study.
Muscle Nerve
; 58(2): 213-218, 2018 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-29543984